Financials data is unavailable for this security.
View more
Year on year Coloplast A/S grew revenues 10.33% from 24.50bn to 27.03bn while net income improved 5.62% from 4.78bn to 5.05bn.
Gross margin | 67.59% |
---|---|
Net profit margin | 18.69% |
Operating margin | 27.08% |
Return on assets | 10.50% |
---|---|
Return on equity | 28.67% |
Return on investment | 14.49% |
More ▼
Cash flow in DKKView more
In 2024, cash reserves at Coloplast A/S fell by 123.00m. However, the company earned 2.76bn from its operations for a Cash Flow Margin of 10.22%. In addition the company used 1.34bn on investing activities and also paid 1.52bn in financing cash flows.
Cash flow per share | 28.39 |
---|---|
Price/Cash flow per share | 29.20 |
Book value per share | 79.62 |
---|---|
Tangible book value per share | -54.98 |
More ▼
Balance sheet in DKKView more
Current ratio | 1.02 |
---|---|
Quick ratio | 0.6637 |
Total debt/total equity | 1.26 |
---|---|
Total debt/total capital | 0.5578 |
More ▼
Growth rates in DKK
SmartText is unavailable
Div yield(5 year avg) | 2.27% |
---|---|
Div growth rate (5 year) | 5.29% |
Payout ratio (TTM) | 98.10% |
EPS growth(5 years) | 4.33 |
---|---|
EPS (TTM) vs TTM 1 year ago | 1.86 |
More ▼